Kusajili – Clinical trials directory

Result of your search per specialist: Thierry Dantoine

Woman and Man Max 99 years
Thierry Dantoine Update Il y a 4 ans

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment This is a prospective, multicenter, open-label study. Following screening and baseline assessments, eligible patients will be switched to rivastigmine and will enter the 16 week run-in riv...

Country France
organs None
Specialty None

Closed trial

More information